Therapeutic Variables in Cataract Surgery

Innovative Medical

Overview

The purpose of this study is to compare patient outcomes in following cataract surgery in patients randomized to one of two surgical kits.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

DOUBLE

Conditions

Cataract Surgery

Interventions

GatifloxacinDRUG

Ketorolac LSDRUG

Pred ForteDRUG

MoxifloxacinDRUG

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Males or females scheduled to undergo cataract surgery * Patients can be receiving monofocal IOLs only * Likely to complete all study visits and able to provide informed consent * Visual potential of 20/25 or better Exclusion Criteria: * Known contraindications to any study medication or ingredients * Active ocular diseases or uncontrolled systemic disease * Active ocular allergies

Locations (1)

The Center for Excellence in Eye Care

Miami, Florida, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.